References
- Gottlieb AB, Product development for psoriasis: clinical challenges and opportunities. Psoriasis (1998) 3: 421–33.
- Al Suwaidan SN, Feldman SR, Clearance is not a realistic expectation of psoriasis treatment. J Am Acad Dermatol (2000) 42: 796–802.
- Zarkowsky H, Managed care organizations’ assessment of reimbursement for new technology, procedures, and drugs. Arch Pathol Lab Med (1999) 123: 677–9.
- Housman TS, Mellen BG, Rapp SR et al, Patients with psoriasis prefer solution and foam vehicles: a quantitative assessment of vehicle preference. Cutis (2002) 70: 327–32.
- Bonis B, Kemeny L, Dobozy A et al, 308 nm UVB excimer laser for psoriasis. Lancet (1997) 350: 1522[letter].
- Feldman SR, Mellen BG, Salam TN et al, Efficacy of the 308-nm excimer laser for treatment of psoriasis: results of a multicenter study. J Am Acad Dermatol (2002) 46: 900–6.
- Koo J, Lebwohl M, Duration of remission of psoriasis therapies. J Am Acad Dermatol (1999) 41: 51-9. Asawanonda P, Anderson RR, Chang Y, Taylor CR, 308-nm excimer laser for the treatment of psoriasis: a dose-response study. Ardch Dermatol (2000) 136: 619–24.